Please login to the form below
13
Revenue 2017Bristol-Myers Squibb
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.
Bristol Myers Squibb announces positive trial results for treatment of MS
Bristol Myers Squibb (BMS) announced that analysis from two phase 3 trials of Zeposia (ozanimod) showed that early use of the treatment demonstrated cognitive benefits in people with relapsing multiple sclerosis
Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
Bristol Myers Squibb has revealed two-year results from the POETYK PSO trial involving its psoriasis therapy, deucravacitinib. ... Jonathan Sadeh, senior vice president of immunology and fibrosis development at Bristol Myers Squibb, said: “Our
BMS Foundation announces Robert A Winn Diversity in Clinical Trials Award Program
The Bristol Myers Squibb Foundation (BMSF), the National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR) have revealed a new name for its initiative to increase clinical trial ... Commenting on Winn’s contributions,
FDA approves BMS’s Opdualag for metastatic or unresectable melanoma
Bristol Myers Squibb (BMS) has announced that Opdualag (nivolumab and relatlimab-rmbw) has received approval from the US Food and Drug Administration (FDA) for the treatment of adult and paediatric patients
FDA approves BMS’ Opdivo with chemotherapy for certain lung cancer patients
Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has approved Opdivo (nivolumab) for use in combination with chemotherapy every three weeks for three cycles.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Biogen and Happify Health team up to create digital platform for MS patients
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
- Moderna to launch Innovation and Technology Center in the UK
- Happify Health and Almirall launch Claro to support psoriasis patients
- 6 trends shaping the future of personalized medicine
- Omnichannel strategies to revolutionize the healthcare professional experience
- The digital-first launch: the key to connected stakeholder experiences?
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Bristol Myers Squibb announces positive trial results for treatment of MS
- ‘The man behind the mouse’: bringing courage to creativity in healthcare communications
- EFPIA-EURORDIS joint statement published on patient access to medicines for rare diseases
- Novartis announces promising five-year data for leukaemia treatment Kymriah
- A creative awakening – how pharma is bringing innovation to the patient journey
- FDA grants Pfizer/BioNTech’s COVID-19 vaccine emergency use authorisation for infants
- New virtual health and care report from WHO and Novartis calls for ‘critical action’
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
- Omnichannel strategies to revolutionize the healthcare professional experience
- Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...
- The digital-first launch: the key to connected stakeholder experiences?
- During the COVID-19 pandemic, a new digital-first launch model emerged as a gamechanger for driving better customer experiences. Here, Senior Consultant Srividya Sekar; Senior Associate Consultant, Erin Johnstone; and Associate...
